![]() |
||
![]() |
||
![]() |
||
Conference Menu
概要
Novel Vaccines
Advances In Cancer Vaccines
Clinical Risk Management For Vaccines
住宿及旅游
赞助/展出
海报发表
询问
报名
Sponsoring Publications
Corporate Sponsor: |
Advances In Cancer Vaccines - 概要![]() The Advances in Cancer Vaccines主要锁定在利用免疫系统来对抗癌症之生物疗法。来自企业界、学术团体、政府部门之关键人士将针对仿人类单株抗体技术(Humanized monoclonal antibodies)、可溶解接受器(soluble receptor)、免疫抑制剂(immunorepressant)、肿瘤治疗等具挑战性领域之发展现况,进行发表。 来自世界各地之学者专家将癌治疗分野之免疫疗法(immunotherapeutic)现阶段之挑战及突破进行议论。
Opportunities and Challenges for Cancer VaccinesUna Ryan, Ph.D., President & CEO, AVANT Immunotherapeutics Inc.
Vaccine, Immunotherapy and the Immunological Constant or RejectionFrancesco M. Marincola, Ph.D., Chief, Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health
Dendritic Cell Tumor Fusions from the Bench to the BedsideDavid Avigan, M.D., Director, Hematological Malignancies/Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, Harvard Medical School
GVAX Immunotherapy for Prostate CancerKristen M. Hege, M.D., Vice President, Clinical Research and Development, Cell Genesys |
|
|
中文官方网站营运:Cambridge Healthtech Institute 代理商 日商环球讯息有限公司
|
||